AHSN Impact Report 2022 | Page 35

aftermath of a global pandemic , with an additional emphasis on addressing health inequalities .
In response , we saw a range of health innovations designed to ease pressures on NHS resources .
This year , we were delighted to welcome a new partner on board - the global pharmaceutical company , Pfizer - who joined alongside our existing partners : Nexus at the University of Leeds , Hill Dickinson , Barclays Eagle Labs and Leeds City Council .
Our partners were selected based on the value they could bring to the programme to help the innovators meet the specific demands of the NHS . It was also important that they could provide support on all aspects of building a successful and sustainable business , and were either local to the region or were national companies that have a strong footprint here .
Twenty-two companies applied for this year ’ s accelerator , with 10 companies chosen following a rigorous application process and selection day .
The 10 companies chosen to become our third cohort were :
Chatterbug – a social enterprise supporting children and young people with speech and language difficulties .
Genome – a digital health company developing advanced quality assurance and improvement software for health and social care organisations .
Heyr – a mental health app .
Hummingbird Medical – a ‘ BookYourGP ’ tool that helps to organise complex medical care for GPs .
Rewire Stroke – using data and clinical best practice to deliver personalised stroke therapy .
PhysioBuddie – an online therapy service that provides its users with remote step-by-step progressive rehabilitation .
Promatica – a digital management system for social prescribing by Social RX .
Syrona Health – the ‘ Sora ’ app is a digital health platform supporting chronic gynaecological conditions like endometriosis , PCOS and menopause .
Your Meds – a smart medication system that helps people take the right medication at the right time , with support from family and friends .
Vitacam – this product transforms routine clinical observations from manual contact-based methods to contactless measurements .
Financial support , benefit in kind specialist expertise and mentorship has been provided for this programme to Yorkshire & Humber Academic Health Science Network as a donation by Pfizer Ltd .
35 Transforming Lives Through Innovation